Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine. - Johnson MP; Krikke-Workel J; Patel CN; Morin SM; Turner PK; Clark KA; Donley D; Jin Y; Johnson KW; Vincent M; Stille JR; Broad LM; et al. (Cephalalgia : an international journal of headache, 2025)